Biography
Brady heads business development, market development and strategy for Canexia Health where we make high-quality cancer genomic information accessible and affordable with our clinically validated assays, informatics, and support. As part of the Executive Management Team, Brady's responsibilities include developing and managing all Business Development and Market Development activities as well as Partnerships and Joint Ventures. Brady works closely with the CEO to set the companies 3-year strategy and keep the company on track to execute to plan. Prior to Canexia Health Brady lead strategy, market development and marketing for DNAnexus. Brady worked with the commercial and product development leads to accelerate new market opportunities as well as leading the marketing team. Brady was also responsible for building strategic partnerships with both technology and services-based organizations and as a member of the Executive Team is responsible for setting corporate strategy, running corporate development and innovation activities.

Biography
Dr. Hulick is the Medical Director of the Mark R. Neaman Center for Personalized Medicine and Division Head for the Center for Medical Genetics at NorthShore University HealthSystem, which applies genomic information to prevention, diagnosis and treatment of human disease with the vision to bring genomics guided care to every patient and their family. He joined NorthShore as an attending physician in medical genetics in 2008 and became Division Head of Medical Genetics in 2012. Dr. Hulick also serves as a Clinical Assistant Professor in the Department of Human Genetics at the University of Chicago Pritzker School of Medicine. Previously, he served as an attending physician in medical genetics at Massachusetts General Hospital. Dr. Hulick earned his medical degree from Jefferson Medical College in 2001. He completed a residency in internal medicine at St. Luke’s Hospital – Mayo Clinic, and completed a clinical fellowship in medical genetics at Harvard Medical School.

Biography
Thuy Phung, MD, PhD is associate professor and medical director of molecular pathology & dermatopathology at the University of South Alabama. She has been spearheading efforts to enhance molecular diagnostics for cancer patients in underserved areas in the Gulf Coast region by establishing rapid single-gene testing as well as actionable, cost-effective next generation sequencing (NGS) assays. She is the lead author of Pediatric Dermatopathology, a comprehensive textbook in the field. Dr. Phung is passionate about global health. She co-founded the award-winning Vascular Anomalies Center in Ho Chi Minh City, Vietnam, which cares for thousands of underserved children with vascular birthmarks, and is leading efforts to establish molecular diagnostics for these disorders.

Biography
Mike Datto, MD, PhD is an AP/CP/MGP board-certified pathologist, vice chair of clinical pathology for the department of pathology at Duke University and the medical director and associate vice president for Duke University Health System Clinical Laboratories. In his role as associate vice president, Datto is responsible for maintaining the standards of the College of American Pathologists and CLIA/CMS within all clinical laboratories at Duke. Specifically, Datto oversees clinical testing; develops quality management systems and proficiency testing programs; provides consultation with ordering physicians; develops strategic plans in line with patient, physician and health system leadership needs; coordinates research and development; ensures adequate and appropriately trained personnel; and provides profession interpretation for molecular diagnostic testing including the wide range of PCR, quantitative PCR, sequencing, NGS and FISH based tests for inherited genetic diseases, hematologic malignancies, solid tumors and infectious diseases. In the past, Datto worked in the Lab of Xiao-Fan Wang, defining the mechanisms by which transforming growth factor beta exerts its cellular actions in health and disease. Following the completion of medical school, Datto trained as a resident in pathology at Duke. He has been on faculty in the department of pathology ever since. Outside of Duke, Datto has served on many national committees as a leader in laboratory medicine, including service to the College of American Pathologists as the Chair of the Accreditation Committee, and overseeing the accreditation decisions for all CAP accredited laboratories. Datto received a BA from Johns Hopkins University in Biology. He went on to receive his MD and PhD from Duke University as part of the Medical Scientists Training Program.